The efficacy of Shatyadhi churna in the management of vataja pratisyaya (allergic rhinitis) in children- A randomized controlled clinical trial.

All India Institute of Ayurveda0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1. Age group 6 to 16 years irrespective of their sex.
•2. Patients having following 4 or more diagnostic symptoms of vatajapratishaya ie.
•a)Kshavathu(sneezing),
•b)nasa srava(rhinorrhea),
•c)Nasauparodha(nasa blockage) ,
•d)mukha shosha(dry mouth) ,
•e)sirasoola(headache) ,
•f)nasa –bru kandu(itchy nose –eyebrow)
•-for a minimum of one year immediately preceding the study Screening Visit.
•A minimum score of 4 on Vataja pratisyaya severity score index will be included in the study.
•3. Gives written informed consent (parent/legal guardian) and assent (from the child), including privacy authorization as well as adherence to concomitant medication withholding periods, prior to participation.

•1.Age under 6 years and above 16 years irrespective of sex.
•2.Patients having lower respiratory tract infection.
•3.Upper Respiratory complaints such as Nasal polyposis, Nasal tumours.
•4.Patients with adenotonsillar hypertrophy, craniofacial syndromes, or neuromuscular diseases.
•5.Patients with history of nasal surgery.
•6.Other respiratory infectious conditions such as Tuberculosis, Plural effusion, Emphysema, Lung abscess, Bronchiectasis, pneumonia, Pleurisy.
•7.Congenital anomalies of respiratory tract or rhinitis due to trauma.
•8.Patients suffering from chronic debilitating diseases like JDM, HIV, HBsAg, immune compromised children etc.
•9.Patients who are not willing to be included in the study protocol and also who are not willing to give the consent for the study.

发起方